arbaclofen
Showing 1 - 11 of 11
Multiple Sclerosis, Spasticity, Muscle Trial in Fresno (Arbaclofen)
Completed
- Multiple Sclerosis
- Spasticity, Muscle
- Arbaclofen
-
Fresno, CaliforniaNeuro Pain Medical Center
Jul 14, 2022
16P11.2 Deletion Syndrome Trial in Boston, Houston, Seattle (Arbaclofen, Placebo oral tablet)
Suspended
- 16P11.2 Deletion Syndrome
- Arbaclofen
- Placebo oral tablet
-
Boston, Massachusetts
- +2 more
Jul 28, 2021
Multiple Sclerosis, Spasticity, Muscle Trial in Worldwide (Arbaclofen, Placebo)
Completed
- Multiple Sclerosis
- Spasticity, Muscle
- Arbaclofen
- Placebo
-
Grodno, Belarus
- +29 more
Jul 12, 2022
Spasticity, Multiple Sclerosis Trial in Russian Federation, Ukraine, United States (arbaclofen, baclofen, Placebo)
Completed
- Spasticity
- Multiple Sclerosis
- arbaclofen
- +2 more
-
Cullman, Alabama
- +47 more
Apr 21, 2022
Fragile X Syndrome Trial in United States (arbaclofen, Placebo)
Completed
- Fragile X Syndrome
- arbaclofen
- Placebo
-
Phoenix, Arizona
- +27 more
Jul 30, 2013
Autism Spectrum Disorders Trial in United States (Arbaclofen)
Completed
- Autism Spectrum Disorders
- Arbaclofen
-
Phoenix, Arizona
- +23 more
Jul 30, 2013
Fragile X Syndrome Trial in United States (arbaclofen, )
Completed
- Fragile X Syndrome
- arbaclofen
- placebo
-
Phoenix, Arizona
- +23 more
Jul 30, 2013
Fragile X Syndrome Trial in United States (arbaclofen)
Terminated
- Fragile X Syndrome
- arbaclofen
-
Phoenix, Arizona
- +22 more
Jul 30, 2013
Autism Spectrum Disorders Trial in United States (arbaclofen)
Terminated
- Autism Spectrum Disorders
- arbaclofen
-
Phoenix, Arizona
- +7 more
Dec 19, 2012
Fragile X Syndrome Trial in United States (Arbaclofen)
Terminated
- Fragile X Syndrome
- Arbaclofen
-
Los Angeles, California
- +8 more
Dec 19, 2012